With the aid of three basic organic compounds, 2-pyrazinoylguanidine, 3-amino-2-pyrazinoylguanidine, and 3,5-diamino-6-fluoro-2-pyrazinoylguanidine, urea was shown to be secreted by the renal tubules of the dog both from the lumen and into the lumen independent of urine flow.
of the frog renal tubules (4, 5) .
The possibility that urea is actively transported across the nephron of mammals has been contemplated as investigators have interpreted their data (6) (7) (8) (9) . However, the teaching prevails that in the dog and human urea undergoes glomerular filtration and passive reabsorption (back diffusion) as it passes along the lumen of the tubule. This view derives from the long-standing approximation that the reabsorption ofurea varies inversely with its transit time for back diffusion along the tubule (10, 11) . By 1977 the availability and use of certain compounds in our studies made it reasonably certain to us that urea is actively secreted into and from the lumen of the renal tubules of the dog in addition to its (passive) back diffusion from the lumen. With the aid of three experiments in dogs involving three compounds, we illustrate what we call active urea transport, active in the sense that inhibition thereof at nontoxic doses of those compounds is structure (and dose) dependent. The renal clearance procedures for trained female dogs were those employed in and published from the senior investigator's laboratory for many years (e.g., ref. 12 ).
First, a three-phase renal clearance experiment is summarized in Table 1 . The initial phase, at spontaneous, low, urine flow, illustrates duplicate normal values for the several parameters based on the diets for the dogs at that time. In the second phase, urine flow was increased to about 4 ml/min to minimize the factor of back diffusion, by the infusion of hypertonic (10%) mannitol solution at 10 ml/min. Urea clearance was increased thereby and was attributable to the reduced transit time for back diffusion (increased urine volume per min). Na' and K+ output increased for much the same reason. The plasma urea concentration was reduced. Decrease in plasma urea concentration in the second phase of the experiment may have been attributable in part to plasma volume expansion, but the increased urea/creatinine clearance ratio (CR) indicated that a greater proportion of the amount of urea filtered was excreted, because of reduced time for (passive) back diffusion. In the third (drug) phase, 3-amino-2-pyrazinoylguanidine increased both urea clearance and urea/creatinine clearance ratio. The increase in urea/creatinine clearance ratio was attended by a progressive reduction in urea plasma concentration. The compound increased Na+ excretion but not K . Although the increased urea/creatinine clearance ratio (1.07-1.12) in the drug phase might be taken to indicate that the high urine flow and inhibitory drug effect combined to inhibit urea reabsorption completely, such an interpretation may be imprecise.
Analogous to uric acid transport (13) , active urea secretion into the lumen of the tubule could be demonstrated clearly when such a two-phase protocol was employed in the Dalmatian coach hound (Table 2 ). In such an experiment conducted at low urine flow, 3,5-diamino-6-fluoro-2-pyrazinoylguanidine so completely inhibited active secretion of urea by the tubules into their lumena that its concentration became indeterminately low in urine. Plasma urea concentration increased over the 2.5-hr drug phase. Even sodium (chloride) and potassium were largely reabsorbed under these conditions.
The reabsorptive component of the bidirectional active transport of urea can be clearly demonstrated in the Dalmatian coach hound also (Table 3) . 2-Pyrazinoylguanidine increased urea clearance and clearance ratio and decreased plasma urea concentration in the Dalmatian when the same protocol was used as for Table 2 . Note that although the drug induced an increase in inorganic electrolyte excretion, the slightly hypotonic mannitol helped to sustain a uniformly low urine flow so as not to alter passive back-diffusion unduly.
It is of significance that urea clearance can be manipulated by use of inhibitors of its active transport. Whereas these experiments illustrate inhibition of active renal transport of urea in the dog, with our clinical associates we have extended our interests to the inhibition of urea reabsorption by the kidney of humans-normal, hypertensive, and those having renal insufficiency.
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